Phenotypes of Escherichia coli isolated from urine: Differences between extended-spectrum β-lactamase producers and sensitive strains

Journal of Microbiology, Immunology and Infection

Volumn 48, Issue 3, 2015, Pages 329-334

  Šišková, Petra ^a   Černohorská, Lenka ^a   Mahelová, Martina ^a   Turková, Kristýna ^b   Woznicová, Vladana ^a  

^a ST ANNE S UNIVERSITY HOSPITAL   (Czech Republic)

^b BRNO UNIVERSITY OF TECHNOLOGY   (Czech Republic)

Author keywords

Biochemistry; Escherichia coli; Extended spectrum lactamase; Phenotype

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ARGININE; BACTERIAL ANTIGEN; CEFALOTIN; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; ERTAPENEM; ESCULIN; EXTENDED SPECTRUM BETA LACTAMASE; GALACTITOL; GENTAMICIN; GLUCOSE; INOSITOL; LYSINE; MELIBIOSE; O25 ANTIGEN; ORNITHINE; RAFFINOSE; RHAMNOSE; RIBITOL; SORBITOL; SUCROSE; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; BETA LACTAMASE; O ANTIGEN;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC SENSITIVITY; ANTIGEN ANTIBODY REACTION; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATION; BIOFILM; BRAIN; BRAIN HEART PERFUSION; COMPARATIVE STUDY; CONTROLLED STUDY; ESCHERICHIA COLI; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ESCHERICHIA COLI; FEMALE; GENETIC VARIABILITY; HEART; HEMOLYSIS; HUMAN; INFUSION; MALE; NONHUMAN; OPTICAL DENSITY; PHENOTYPE; PULSED FIELD GEL ELECTROPHORESIS; URINE; ANTIBIOTIC RESISTANCE; BACTERIUM IDENTIFICATION; CELL WALL; CHEMISTRY; CLASSIFICATION; ESCHERICHIA COLI INFECTION; GENETIC VARIATION; GENETICS; GENOTYPE; GROWTH, DEVELOPMENT AND AGING; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIDDLE AGED; PHYSIOLOGY; SECRETION (PROCESS); URINARY TRACT INFECTION; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIAL TYPING TECHNIQUES; BETA-LACTAMASES; BIOFILMS; CELL WALL; CIPROFLOXACIN; DRUG RESISTANCE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; GENETIC VARIATION; GENOTYPE; HEMOLYSIS; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; O ANTIGENS; ORNITHINE; PHENOTYPE; URINARY TRACT INFECTIONS; URINE; YOUNG ADULT;

EID: 84929517793     PISSN: 16841182     EISSN: 19959133     Source Type: Journal    
DOI: 10.1016/j.jmii.2014.04.010     Document Type: Article

References (32)

1. Davis N.F., Flood H.D. The Pathogenesis of Urinary Tract Infections. Clinical Management of Complicated Urinary Tract Infection 2011, InTech, Available at:, [accessed 31.01.14]. http://www.intechopen.com/books/clinical-management-of-complicated-urinary-tract-infection/the-pathogenesis-of-urinary-tract-infections, 10.5772/22308. D. Ahmad Nikibakhsh (Ed.).
2. Wiles T.J., Kulesus R.R., Mulvey M.A. Origins and virulence mechanisms of uropathogenic Escherichia coli. Exp Mol Pathol 2008, 85:11-19.
3. Totsika M., Moriel D.G., Idris A., Rogers B.A., Wurpel D.J., Phan M.D., et al. Uropathogenic Escherichia coli mediated urinary tract infection. Curr Drug Targets 2012, 13:1386-1399.
4. Bitsori M., Maraki S., Kalmanti M., Galanakis E. Resistance against broad-spectrum β-lactams among uropathogens in children. Pediatr Nephrol 2009, 24:2381-2386.
5. Geerlings S.E. Urinary tract infections in patients with diabetes mellitus: epidemiology, pathogenesis and treatment. Int J Antimicrob Agents 2008, 31S:S54-S57.
6. Wang M.C., Tseng C.C., Wu A.B., Lin W.H., Teng C.H., Yan J.J., et al. Bacterial characteristics and glycemic control in diabetic patients with Escherichia coli urinary tract infection. J Microbiol Immunol Infect 2013, 46:24-29.
7. Mainil J. Escherichia coli virulence factors. Vet Immunol Immunopathol 2013, 152:2-12.
8. Alteri C.J., Mobley H.L. Escherichia coli physiology and metabolism dictates adaptation to diverse host microenvironments. Curr Opin Microbiol 2012, 15:3-9.
9. Köhler C.D., Dobrindt U. What defines extraintestinal pathogenic Escherichia coli?. Int J Med Microbiol 2011, 301:642-647.
10. Diard M., Garry L., Selva M., Mosser T., Denamur E., Matic I. Pathogenicity-associated islands in extraintestinal pathogenic Escherichia coli are fitness elements involved in intestinal colonization. J Bacteriol 2010, 192:4885-4893.
11. Hilbert D.W., Paulish-Miller T.E., Tan C.K., Carey A.J., Ulett G.C., Mordechai E., et al. Clinical Escherichia coli isolates utilize alpha-hemolysin to inhibit in vitro epithelial cytokine production. Microbes Infect 2012, 14:628-638.
12. Carneiro S., Ferreira E.C., Rocha I. Metabolic responses to recombinant bioprocesses in Escherichia coli. J Biotechnol 2013, 164:396-408.
13. Nicolas-Chanoine M.H., Blanco J., Leflon-Guibout V., Demarty R., Alonso M.P., Caniça M.M., et al. Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. J Antimicrob Chemother 2008, 61:273-281.
14. Gibreel T.M., Dodgson A.R., Cheesbrough J., Fox A.J., Bolton F.J., Upton M. Population structure, virulence potential and antibiotic susceptibility of uropathogenic Escherichia coli from Northwest England. J Antimicrob Chemother 2012, 67:346-356.
15. Johnson J.R., Nicolas-Chanoine M.H., DebRoy C., Castanheira M., Robicsek A., Hansen G., et al. Comparison of Escherichia coli ST131 pulsotypes, by epidemiologic traits, 1967-2009. Emerg Infect Dis 2012, 18:598-607.
16. Totsika M., Beatson S.A., Sarkar S., Phan M.D., Petty N.K., Bachmann N., et al. Insights into a multidrug resistant Escherichia coli pathogen of the globally disseminated ST131 lineage: genome analysis and virulence mechanisms. PLoS One 2011, 6:e26578.
17. Clermont O., Lavollay M., Vimont S., Deschamps C., Forestier C., Branger C., et al. The CTX-M-15-producing Escherichia coli diffusing clone belongs to a highly virulent B2 phylogenetic subgroup. J Antimicrob Chemother 2008, 61:1024-1028.
18. Prüß B.M., Verma K., Samanta P., Sule P., Kumar S., Wu J., et al. Environmental and genetic factors that contribute to Escherichia coli K-12 biofilm formation. Arch Microbiol 2010, 192:715-728.
19. Votava M., Woznicová V. Production of slime by staphylococcal isolates from blood cultures. Cent Eur J Public Health 2000, 8:18-20.
20. Gallant C.V., Daniels C., Leung J.M., Ghosh A.S., Young K.D., Kotra L.P., et al. Common β-lactamases inhibit bacterial biofilm formation. Mol Microbiol 2005, 58:1012-1024.
21. Soto S.M., Francesc M., Guiral E., Vila J. Biofilm formation in uropathogenic Escherichia coli strains: relationship with urovirulence factors and antimicrobial resistance, clinical management of complicated urinary tract infection 2011, InTech, Available at:, [accessed 31.01.14]. http://www.intechopen.com/books/clinical-management-of-complicated-urinary-tract-infection/biofilm-formation-in-uropathogenic-escherichia-coli-strains-relationship-with-urovirulence-factors-a, 10.5772/24626.
22. Performance standards for antimicrobial susceptibility testing: sixteenth informational supplement 2006, Clinical and Laboratory Standard Institute, CLSI document M100-MS16, Clinical and Laboratory Standard Institute, Wayne, PA.
23. Stepanović S., Vuković D., Holá V., Di Bonavertura G., Djukić S., Cirković I., et al. Quantification of biofilm in microtiter plates: overview of testing conditions and practical recommendations for assessment of biofilm production by staphylococci. APMIS 2007, 115:891-899.
24. Goering R.V. Pulsed field gel electrophoresis: A review of application and interpretation in the molecular epidemiology of infectious disease. Infect Genet Evol 2010, 10:866-875.
25. Ho P.L., Wong R.C., Yip K.S., Loke S.L., Leung M.S., Mak G.C., et al. Antimicrobial resistance in Escherichia coli outpatient urinary isolates from women: emerging multidrug resistance phenotypes. Diagn Microbiol Infect Dis 2007, 59:439-445.
26. Jadhav S., Hussain A., Devi S., Kumar A., Parveen S., Gandham N., et al. Virulence characteristics and genetic affinities of multiple drug resistant uropathogenic Escherichia coli from a semi urban locality in India. PLoS One 2011, 6:e18063.
27. Vieira G., Sabarly V., Bourguignon P.Y., Durot M., Le Fèvre F., Mornico D., et al. Core and Panmetabolism in Escherichia coli. J Bacteriol 2011, 193:1461-1472.
28. Maluta R.P., Stella A.E., Riccardi K., Rigobelo E.C., Marin J.M., Carvalho M.B., et al. Phenotypical characterization and adhesin identification in Escherichia coli strains isolated from dogs with urinary tract infections. Braz J Microbiol 2012, 43:375-381.
29. Foubister V., Rosenshine I., Finlay B.B. A diarrheal pathogen, enteropathogenic Escherichia coli (EPEC), triggers a flux of inositol phosphates in infected epithelial cells. J Exp Med 1994, 179:993-998.
30. Sason H., Milgrom M., Weiss A.M., Melamed-Book N., Balla T., Grinstein S., et al. Enteropathogenic Escherichia coli subverts phosphatidylinositol 4,5-bisphosphate and phosphatidylinositol 3,4,5-trisphosphate upon epithelial cell infection. Mol Biol Cell 2009, 20:544-555.
31. Hagan E.C., Lloyd A.L., Rasko D.A., Faerber G.J., Mobley H.L. Escherichia coli global gene expression in urine from women with urinary tract infection. PLoS Pathog 2010, 6:e1001187.
32. Brzuszkiewicz E., Brüggemann H., Liesegang H., Emmerth M., Ölschläger T., Nagy G., et al. How to become a uropathogen: comparative genomic analysis of extraintestinal pathogenic Escherichia coli strains. Proc Natl Acad Sci U S A 2006, 103:12879-12884.